We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
+0.6%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$19.3B
AUM Growth
-$1.09B
Cap. Flow
-$60.5M
Cap. Flow %
-0.31%
Top 10 Hldgs %
26.11%
Holding
463
New
43
Increased
126
Reduced
234
Closed
29

Top Buys

Rank Stock Value
1
DUOL icon
Duolingo
DUOL
+$154M
2
CFLT
Confluent
CFLT
+$146M
3
TOST icon
Toast
TOST
+$139M
4
SNOW icon
Snowflake
SNOW
+$66.8M
5
CURV icon
Torrid Holdings
CURV
+$66.6M

Sector Composition

Rank Sector Weight
1 Technology 34.48%
2 Consumer Discretionary 18.43%
3 Healthcare 18.09%
4 Communication Services 11.29%
5 Miscellaneous 5.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APEN
276
DELISTED
Apollo Endosurgery, Inc.
APEN
$1.94M 0.01%
214,053
+55,717
+35% +$479K
LOVE
277
LoveSac
LOVE
$215M
$1.86M 0.01%
28,095
S icon
278
SentinelOne
S
$8.17B
$1.85M 0.01%
34,525
-475
-1% -$26.1K
ALLK
279
DELISTED
Allakos
ALLK
$1.79M 0.01%
16,883
-458
-3% -$40.9K
CCCC icon
280
C4 Therapeutics
CCCC
$422M
$1.76M 0.01%
+39,506
New +$1.69M
ATVI
281
DELISTED
Activision Blizzard
ATVI
$1.75M 0.01%
22,576
+37
+0.2% +$3.09K
VOR icon
282
Vor Biopharma
VOR
$1.32B
$1.73M 0.01%
5,512
-8,522
-61% -$2.53M
RARE icon
283
Ultragenyx Pharmaceutical
RARE
$1.29B
$1.63M 0.01%
18,060
-284
-2% -$25.7K
OLPX
284
DELISTED
Olaplex Holdings
OLPX
$1.58M 0.01%
+64,504
New +$1.58M
NPTN
285
DELISTED
NEOPHOTONICS CORP
NPTN
$1.57M 0.01%
180,083
-3,783
-2% -$34.5K
MGPI icon
286
MGP Ingredients
MGPI
$308M
$1.52M 0.01%
23,402
-15
-0.1% -$961
ACCD
287
DELISTED
Accolade Inc
ACCD
$1.45M 0.01%
34,482
-1,028,492
-97% -$48.3M
BRK.B icon
288
Berkshire Hathaway Class B
BRK.B
$1.11T
$1.41M 0.01%
5,148
-1
-0% -$281
HMHC
289
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$1.39M 0.01%
103,167
-17,694
-15% -$223K
SHW icon
290
Sherwin-Williams
SHW
$78.5B
$1.34M 0.01%
4,797
-437
-8% -$128K
WOLF icon
291
Wolfspeed
WOLF
$1.25B
$1.33M 0.01%
16,502
+11
+0.1% +$977
NOVA
292
DELISTED
Sunnova Energy
NOVA
$1.29M 0.01%
39,126
+161
+0.4% +$5.68K
VIRX
293
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$1.21M 0.01%
151,350
+476
+0.3% +$4.69K
NVRO
294
DELISTED
NEVRO CORP.
NVRO
$1.17M 0.01%
10,036
+246
+3% +$32.2K
UBER icon
295
Uber
UBER
$146B
$1.13M 0.01%
25,320
+20
+0.1% +$874
ARLO icon
296
Arlo Technologies
ARLO
$1.45B
$1.1M 0.01%
171,201
+30,283
+21% +$188K
IRTC icon
297
iRhythm Holdings
IRTC
$3.69B
$1.05M 0.01%
17,998
+17,994
+449,850% +$954K
BSX icon
298
Boston Scientific
BSX
$63.6B
$896K ﹤0.01%
20,644
-3
-0% -$133
SLGC
299
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$877K ﹤0.01%
70,806
-1,132
-2% -$12.8K
OLK
300
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$830K ﹤0.01%
34,228
+2,260
+7% +$71K

Similar funds

Gilder Gagnon Howe & Co's Q3 2021 Portfolio in Review

As of Q3 2021, Gilder Gagnon Howe & Co held 463 positions worth $19.3B, down 5.3% from $20.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Gilder Gagnon Howe & Co's Q3 2021 filing shows 43 new, 126 increased, 234 reduced and 29 closed positions. Its largest new stake was Duolingo: 1,014,484 shares worth $169M. The largest sale was Watsco Inc, an estimated $99.3M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 31% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Gilder Gagnon Howe & Co's largest Q3 2021 buy was Duolingo: 1,014,484 shares worth $169M.
  • Gilder Gagnon Howe & Co added most to Confluent in Q3 2021, an estimated $146M increase.
  • Gilder Gagnon Howe & Co's biggest Q3 2021 reduction was Watsco Inc, cutting an estimated $99.3M.
  • Gilder Gagnon Howe & Co fully exited Rodgers Silicon Valley Acquisition Corp. Unit in Q3 2021, selling an estimated $20.7M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 26% of its $19.3B portfolio in Q3 2021.
  • Gilder Gagnon Howe & Co opened 43 new positions and closed 29 in Q3 2021.
  • Gilder Gagnon Howe & Co's portfolio value fell 5.3% quarter-over-quarter to $19.3B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2021, filed 15 Nov 2021.